Vident Advisory, LLC Maravai Lifesciences Holdings, Inc. Transaction History
Vident Advisory, LLC
- $5.7 Trillion
- Q4 2024
A detailed history of Vident Advisory, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 28,385 shares of MRVI stock, worth $119,217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,385
Previous 28,483
0.34%
Holding current value
$119,217
Previous $237 Million
34.64%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding MRVI
# of Institutions
201Shares Held
139MCall Options Held
250KPut Options Held
22.8K-
Gtcr LLC20.2MShares$84.6 Million10.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$49.6 Million0.0% of portfolio
-
12 West Capital Management LP New York, NY11.6MShares$48.7 Million6.99% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$40.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$35.1 Million2.55% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $552M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...